false
0001435064
0001435064
2026-05-15
2026-05-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): May 15, 2026

Cemtrex
Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-37464 |
|
30-0399914 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
276
Greenpoint Ave Bld. 8 Suite 208
Brooklyn,
NY |
|
11222 |
| (Address of principal executive
offices) |
|
(Zip Code) |
Registrant’s
telephone number, including area code: (631) 756-9116
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
| Title of
each class |
|
Trading symbol |
|
Name of each
exchange on which registered |
| Common Stock |
|
CETX |
|
Nasdaq Capital Market |
CURRENT
REPORT ON FORM 8-K
Cemtrex,
Inc.
Item
5.07 Submission of Matters to a Vote of Security Holders.
On
May 15, 2026, the Annual Meeting of Shareholders (the “Annual Meeting”) of Cemtrex Inc. (“Centrex” or “Company”)
was held. information about the proposals set forth, please see the Company’s 2025 Proxy Statement. On the record date of March
17, 2026, there were 10,078,089 shares of the Company’s common stock issued, outstanding and entitled to vote, 5,553,638 votes
of the Company’s Series 1 Preferred Stock, and 100,881,671 votes of the Company’s Series C Preferred Stock held by Saagar
Govil, CEO and Chairman of the Board of Directors of the Company, for a total of 116,513,938 voting shares. At the Annual Meeting, a
total of 107,636,697 voting shares (for a quorum of 92.38%) were represented in person or by proxy at the meeting. Set
forth below are the final voting results for the proposals voted on at the Annual Meeting.
Proposal
1 – Voting to elect four nominees to the Company’s Board of Directors (the “Board”) for a one-year expiring at
the next Annual Meeting of Shareholders, or until their successors are elected and qualified.
| | |
Number of Votes | |
| Nominee | |
For | | |
Abstain | | |
Broker Non-Votes | |
| Saagar Govil | |
| 102,741,275 | | |
| 495,703 | | |
| 4,399,719 | |
| Brian Kwon | |
| 102,988,319 | | |
| 248,658 | | |
| 4,399,720 | |
| Manpreet Singh | |
| 102,954,394 | | |
| 282,583 | | |
| 4,399,720 | |
| Mitodi Filipov | |
| 102,987,501 | | |
| 249,476 | | |
| 4,399,720 | |
Each
nominee was elected by the Company’s shareholders, consistent with the recommendation from the Board.
Proposal
2 - Ratification of the Appointment of the Company’s Independent registered public accounting firm: Voting to ratify Grassi Co.
Certified Public Accountants as the Company’s independent registered public accounting firm for the fiscal year ending September
30, 2026:
| |
● |
For: 107,273,002 |
| |
● |
Against: 125,857 |
| |
● |
Abstain; 237,838 |
Proposal
2 was approved by the Company’s shareholders, consistent with the recommendation from the Board.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
| Exhibit Number |
|
Exhibit Title |
| 104 |
|
Cover Page Interactive Data File (embedded within the
Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
CEMTREX, INC. |
| |
|
|
| Date: May 15, 2026 |
By: |
/s/ Saagar Govil |
| |
|
Saagar Govil |
| |
|
Chairman, President and Chief Executive Officer |